HIF-1 — a big chapter in the cancer tale

Approximately 1.0–1.5% of the genome is transcriptionally regulated by hypoxia, and hypoxia-inducible factor (HIF)-1α is the
 transcription factor modulating many of these genes. Cancer cells are able to survive hypoxic environments and hypoxia itself can
 activate adaptive cellular...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2016
Main Author: Ajduković, J.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2016
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/136134
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:HIF-1 — a big chapter in the cancer tale / J. Ajduković // Experimental Oncology. — 2016 — Т. 38, № 1. — С. 9-12. — Бібліогр.: 37 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862737356034932736
author Ajduković, J.
author_facet Ajduković, J.
citation_txt HIF-1 — a big chapter in the cancer tale / J. Ajduković // Experimental Oncology. — 2016 — Т. 38, № 1. — С. 9-12. — Бібліогр.: 37 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Approximately 1.0–1.5% of the genome is transcriptionally regulated by hypoxia, and hypoxia-inducible factor (HIF)-1α is the
 transcription factor modulating many of these genes. Cancer cells are able to survive hypoxic environments and hypoxia itself can
 activate adaptive cellular responses that contribute to tumor progression. Many HIF-1α-mediated biological effects are beneficial
 for tumor progression, including metabolic shift toward glycolysis, inhibition of fatty acid β-oxidation, production of cellular reactive
 oxygen species and altering expression of tumor suppressor genes. HIF-1 promotes selective mitochondrial autophagy, resis- and altering expression of tumor suppressor genes. HIF-1 promotes selective mitochondrial autophagy, resistance
 to T cell mediated lysis of cancer cells, induction of pluripotent cancer stem cells, epithelial-mesenchymal and epithelialmesenchymal-endothelial
 transitions beneficial for tumor growth and progression, loss of E-cadherin. HIF-1 also induces production
 of signal molecules and cytokines by carcinoma-associated fibroblasts and upregulation of certain microRNAs important for
 cancer progression. This minireview focuses on the HIF-1 promoting role in tumor initiation and progression and HIF-1 targeting.
 HIF-1 pathway downregulation seems to be promising in future cancer treatment.
first_indexed 2025-12-07T19:59:03Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-136134
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-12-07T19:59:03Z
publishDate 2016
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Ajduković, J.
2018-06-15T21:38:49Z
2018-06-15T21:38:49Z
2016
HIF-1 — a big chapter in the cancer tale / J. Ajduković // Experimental Oncology. — 2016 — Т. 38, № 1. — С. 9-12. — Бібліогр.: 37 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/136134
Approximately 1.0–1.5% of the genome is transcriptionally regulated by hypoxia, and hypoxia-inducible factor (HIF)-1α is the
 transcription factor modulating many of these genes. Cancer cells are able to survive hypoxic environments and hypoxia itself can
 activate adaptive cellular responses that contribute to tumor progression. Many HIF-1α-mediated biological effects are beneficial
 for tumor progression, including metabolic shift toward glycolysis, inhibition of fatty acid β-oxidation, production of cellular reactive
 oxygen species and altering expression of tumor suppressor genes. HIF-1 promotes selective mitochondrial autophagy, resis- and altering expression of tumor suppressor genes. HIF-1 promotes selective mitochondrial autophagy, resistance
 to T cell mediated lysis of cancer cells, induction of pluripotent cancer stem cells, epithelial-mesenchymal and epithelialmesenchymal-endothelial
 transitions beneficial for tumor growth and progression, loss of E-cadherin. HIF-1 also induces production
 of signal molecules and cytokines by carcinoma-associated fibroblasts and upregulation of certain microRNAs important for
 cancer progression. This minireview focuses on the HIF-1 promoting role in tumor initiation and progression and HIF-1 targeting.
 HIF-1 pathway downregulation seems to be promising in future cancer treatment.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Minireview
HIF-1 — a big chapter in the cancer tale
Article
published earlier
spellingShingle HIF-1 — a big chapter in the cancer tale
Ajduković, J.
Minireview
title HIF-1 — a big chapter in the cancer tale
title_full HIF-1 — a big chapter in the cancer tale
title_fullStr HIF-1 — a big chapter in the cancer tale
title_full_unstemmed HIF-1 — a big chapter in the cancer tale
title_short HIF-1 — a big chapter in the cancer tale
title_sort hif-1 — a big chapter in the cancer tale
topic Minireview
topic_facet Minireview
url https://nasplib.isofts.kiev.ua/handle/123456789/136134
work_keys_str_mv AT ajdukovicj hif1abigchapterinthecancertale